These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36694186)

  • 1. North Carolina pharmacists' willingness to sell fentanyl test strips: a survey study.
    Marley GT; Ostrach B; Carpenter D
    Harm Reduct J; 2023 Jan; 20(1):10. PubMed ID: 36694186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
    Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
    Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The availability of fentanyl test strips in Georgia community pharmacies.
    Rawal S; Khail JW; Stone RH; Young HN
    J Am Pharm Assoc (2003); 2024; 64(2):524-529.e1. PubMed ID: 38143039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
    Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL
    Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study assessing client understanding and use of fentanyl test strips for harm reduction.
    Barrolle AA; Gable KN; Dell N
    J Am Pharm Assoc (2003); 2023; 63(1):295-300. PubMed ID: 36280433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alabama community pharmacists' knowledge and perceptions regarding fentanyl test strips: A cross-sectional survey.
    Woods S; Blythe E; Valle-Ramos G; Richardson J; Pham K; Diggs K; Harris K; Zhao Y; Hohmann L
    J Am Pharm Assoc (2003); 2024 Jun; ():102148. PubMed ID: 38914293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on Fentanyl Test Strip Use among People Who Inject Drugs in Rural Appalachia.
    Allen ST; O'Rourke A; White RH; Sherman SG; Grieb SM
    Subst Use Misuse; 2020; 55(10):1594-1600. PubMed ID: 32336188
    [No Abstract]   [Full Text] [Related]  

  • 9. Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina.
    Zibbell JE; Peiper NC; Duhart Clarke SE; Salazar ZR; Vincent LB; Kral AH; Feinberg J
    Int J Drug Policy; 2021 Jul; 93():103128. PubMed ID: 33487527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK; Salcedo VJ; Guth A; Rising KL
    J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs.
    Reed MK; Guth A; Salcedo VJ; Hom JK; Rising KL
    Int J Drug Policy; 2022 May; 103():103643. PubMed ID: 35255392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE; Vervoordt A; Lieberman M
    Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot testing fentanyl test strip distribution in an emergency department setting: Experiences, lessons learned, and suggestions from staff.
    Reed MK; Salcedo VJ; Hsiao T; Esteves Camacho T; Salvatore A; Siegler A; Rising KL
    Acad Emerg Med; 2023 Jun; 30(6):626-635. PubMed ID: 36333960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making Harm Reduction More Accessible: Fentanyl Test Strip Awareness and Attitudes among Emergency Department Patients Who Use Drugs.
    Reed MK; Siegler A; Esteves Camacho T; London K; Schaeffer K; Rising KL
    Subst Use Misuse; 2024; 59(3):398-404. PubMed ID: 38270457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
    Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
    Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study.
    Park JN; Tomko C; Silberzahn BE; Haney K; Marshall BDL; Sherman SG
    Addict Behav; 2020 Nov; 110():106529. PubMed ID: 32683172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.
    Goodin A; Fallin-Bennett A; Green T; Freeman PR
    Harm Reduct J; 2018 Jan; 15(1):4. PubMed ID: 29370808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the test strips: laboratory performance of fentanyl test strips.
    Halifax JC; Lim L; Ciccarone D; Lynch KL
    Harm Reduct J; 2024 Jan; 21(1):14. PubMed ID: 38238757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs.
    Park JN; Frankel S; Morris M; Dieni O; Fahey-Morrison L; Luta M; Hunt D; Long J; Sherman SG
    Int J Drug Policy; 2021 Aug; 94():103196. PubMed ID: 33713964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An urgent need for community lot testing of lateral flow fentanyl test strips marketed for harm reduction in Northern America.
    Lieberman M; Badea A; Desnoyers C; Hayes K; Park JN
    Harm Reduct J; 2024 Jun; 21(1):115. PubMed ID: 38877522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.